Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
27.90
-2.07 (-6.91%)
At close: Dec 20, 2024, 4:00 PM
27.89
-0.01 (-0.04%)
After-hours: Dec 20, 2024, 7:10 PM EST
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $1.60 billion as of December 20, 2024. Its market cap has decreased by -45.37% in one year.
Market Cap
1.60B
Enterprise Value
686.67M
1-Year Change
-45.37%
Ranking
Category
Stock Price
$27.90
Market Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $1.60B, an increase of 191.09%. That is a compound annual growth rate of 76.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 20, 2024 | 1.60B | -19.77% |
| Dec 29, 2023 | 1.99B | 262.83% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galapagos NV | 1.75B |
| Recursion Pharmaceuticals | 1.75B |
| MannKind | 1.74B |
| GoodRx Holdings | 1.73B |
| Astrana Health | 1.72B |
| Certara | 1.70B |
| Neumora Therapeutics | 1.70B |
| Celldex Therapeutics | 1.68B |